CSIMarket Company Name, Ticker, Industry, else..
 
Cell Source Inc   (CLCS)
 

Cell Source Inc's Suppliers Performance

CLCS's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CLCS Costs vs Sales of Suppliers Growth

• More on CLCS Suppliers






Cell Source Inc's Comment on Supply Chain


The company outsources production capacity from existing facilities operated by Contract Manufacturing Organizations (CMOs) located near major hospitals or contracts directly with cancer treatment centers that have accredited GMP facilities and experienced cell production staff for Veto Cell production. Initial production centers are intended to support FDA processes and serve the North American, European, and Chinese markets. In the future, the company may transition production from leased or contracted facilities to company-owned standalone facilities, each with an estimated capital cost of at least $10 million, primarily due to the expenses associated with GMP clean rooms. Financing will be required to establish these facilities, with no guarantee of availability.

Cell Source Inc's Comment on Supply Chain


The company outsources production capacity from existing facilities operated by Contract Manufacturing Organizations (CMOs) located near major hospitals or contracts directly with cancer treatment centers that have accredited GMP facilities and experienced cell production staff for Veto Cell production. Initial production centers are intended to support FDA processes and serve the North American, European, and Chinese markets. In the future, the company may transition production from leased or contracted facilities to company-owned standalone facilities, each with an estimated capital cost of at least $10 million, primarily due to the expenses associated with GMP clean rooms. Financing will be required to establish these facilities, with no guarantee of availability.







CLCS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Cell Source Inc 20.27 0.00 -4.72 1
SUBTOTAL 0.00 0.00 0.00 -


Sources: Cell Source Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cell Source Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.